Patent US3089095A successfully refreshed from Google Patents.
Patent US4835185A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4835185A Expired / Lapsed US ⏱️ 0.0 years remaining

Immunomodulator for improving commercial performance of domestic animals

Assignee: Iowa State University Research Foundation Inc
•
Filing: 1987-03-02
•
Granted: 1989-05-30
•
Expires: 2007-03-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The commercial performance of domestic animals is improved by feeding keto-isocaproate (KIC) in a form nutritionally utilizable by the animals. The KIC enhances blastogenesis of the animal's T-lymphocytes and reduces plasma cortisol levels. The result is a favorable effect on the immune function of the animal, and can be used to counteract stress-associated immunosuppression. The method is applicable to beef cattle, dairy cattle, sheep, goats, swine, and poultry, as raised, respectively, for meat, milk, wood, or egg production. Practical benefits may also include increased rates of gain and reduced cholesterol in meats and eggs, and increased milk, wool, and egg yields.

Inventors

  • 👤 Steven L. Nissen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 22:44
CPC Classifications
A; A23; A23K; A23K50/00; A23K50/70; A23K50/75; A23K20/00; A23K20/10; A23K20/105; A23K50/10

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 54 words
The method of activating the blastogenesis function of the immune systems of domestic animals selected from the group consisting of cattle, sheep, goats and swine, comprising administering alphaketoisocaproate (KIC) to the animals, said KIC being in the form utilizable by the animals and being administered in an amount enhancing blastogenesis of their T lymphocytes.
Claim 2
Independent Claim 54 words
The method of activating the blastogenesis function of the immune systems of domestic animals selected from the group consisting of cattle, sheep, goats and swine, comprising administering alphaketoisocaproate (KIC) to the animals, said KIC being in the form utilizable by the animals and being administered in an amount enhancing blastogenesis of their T lymphocytes.
Claim 3
Independent Claim 49 words
The method of counteracting stress-associated plasma cortisol elevation in domestic animals selected from the group consisting of cattle, sheep, goats, and swine, comprising administering alpha-ketoisocaproate (KIC) to the animals, said KIC being in a form utilizable by the animals and being administered in an amount reducing their plasma cortisol.
Claim 4
Independent Claim 49 words
The method of counteracting stress-associated plasma cortisol elevation in domestic animals selected from the group consisting of cattle, sheep, goats, and swine, comprising administering alpha-ketoisocaproate (KIC) to the animals, said KIC being in a form utilizable by the animals and being administered in an amount reducing their plasma cortisol.
Claim 5
Dependent Claim 11 words
The method of claim 2 in which said animals are cattle.
Claim 6
Independent Claim 23 words
The method of claims 1 or 2 in which said KIC is selected from the group consisting of sodium KIC and calcium KIC.
Claim 7
Independent Claim 21 words
The method of claims 1 or 2 in which said KIC is orally administered in admixture with an animal feed material.
Claim 8
Independent Claim 14 words
The method of claims 1 or 2 in which said KIC is parenterally administered.
Claim 9
Independent Claim 30 words
The method of claims 1 or 2 in which said animals are selected from the group consisting of cattle and sheep, and said KIC is administered in a rumen-protected form.
Claim 10
Independent Claim 14 words
The method of claims 1 or 2 in which said KIC is sodium KIC.
Claim 11
Independent Claim 14 words
The method of claims 1 or 2 in which said KIC is calcium KIC.
Claim 12
Independent Claim 13 words
The method of claims 1 or 2 in which said animals are swine.

References Cited (Backward Citations)

US4100161A Cited
US4100293A Cited
US4677121A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-05-29 1992-11-28 1993-05-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-05-29 1996-11-28 1997-05-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-05-29 2000-11-28 2001-05-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag